387 related articles for article (PubMed ID: 31900618)
1. A prospective study on oral adverse effects in head and neck cancer patients submitted to a preventive oral care protocol.
Morais MO; Martins AFL; de Jesus APG; de Sousa Neto SS; da Costa AWF; Pereira CH; Oton-Leite AF; de Freitas NMA; Leles CR; Mendonça EF
Support Care Cancer; 2020 Sep; 28(9):4263-4273. PubMed ID: 31900618
[TBL] [Abstract][Full Text] [Related]
2. Photobiomodulation reduces the impact of radiotherapy on oral health-related quality of life due to mucositis-related symptoms in head and neck cancer patients.
Martins AFL; Morais MO; de Sousa-Neto SS; de Jesus APG; Nogueira TE; Valadares MC; Freitas NMA; Batista AC; Leles CR; Mendonça EF
Lasers Med Sci; 2021 Jun; 36(4):903-912. PubMed ID: 33113075
[TBL] [Abstract][Full Text] [Related]
3. Effect of photobiomodulation on the severity of oral mucositis and molecular changes in head and neck cancer patients undergoing radiotherapy: a study protocol for a cost-effectiveness randomized clinical trial.
Martins AFL; Nogueira TE; Morais MO; Oton-Leite AF; Valadares MC; Batista AC; Freitas NMA; Leles CR; Mendonça EF
Trials; 2019 Feb; 20(1):97. PubMed ID: 30709370
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness randomized clinical trial on the effect of photobiomodulation therapy for prevention of radiotherapy-induced severe oral mucositis in a Brazilian cancer hospital setting.
Lopes Martins AF; Nogueira TE; Morais MO; de Sousa-Neto SS; Oton-Leite AF; Valadares MC; Aires Freitas NM; Leles CR; Mendonça EF
Support Care Cancer; 2021 Mar; 29(3):1245-1256. PubMed ID: 32621262
[TBL] [Abstract][Full Text] [Related]
5. The Effect of Photobiomodulation on Nitrite and Inflammatory Activity in Radiotherapy-Induced Oral Mucositis: A Randomized Clinical Trial.
Martins AFL; Morais MO; Sousa-Neto SS; Oton-Leite AF; Pereira CH; Valadares MC; Freitas NMA; Batista AC; Leles CR; Mendonça EF
Lasers Surg Med; 2021 Jul; 53(5):671-683. PubMed ID: 32997817
[TBL] [Abstract][Full Text] [Related]
6. Low-level laser therapy in treatment of chemoradiotherapy-induced mucositis in head and neck cancer: results of a randomised, triple blind, multicentre phase III trial.
Legouté F; Bensadoun RJ; Seegers V; Pointreau Y; Caron D; Lang P; Prévost A; Martin L; Schick U; Morvant B; Capitain O; Calais G; Jadaud E
Radiat Oncol; 2019 May; 14(1):83. PubMed ID: 31118057
[TBL] [Abstract][Full Text] [Related]
7. Effect of low-level laser therapy on patient reported measures of oral mucositis and quality of life in head and neck cancer patients receiving chemoradiotherapy--a randomized controlled trial.
Gautam AP; Fernandes DJ; Vidyasagar MS; Maiya AG; Nigudgi S
Support Care Cancer; 2013 May; 21(5):1421-8. PubMed ID: 23224689
[TBL] [Abstract][Full Text] [Related]
8. Impact of photobiomodulation for prevention of oral mucositis on the quality of life of patients with head and neck cancer: a systematic review.
Potrich AR; Só BB; Schuch LF; Wagner VP; Silveira FM; de Abreu Alves F; Prado-Ribeiro AC; Santos-Silva AR; Treister NS; Martins MD; Martins MAT
Lasers Med Sci; 2023 Dec; 39(1):1. PubMed ID: 38057605
[TBL] [Abstract][Full Text] [Related]
9. Effects of a mucoadhesive phytomedicine (Curcuma longa L. and Bidens pilosa L.) on radiotherapy-induced oral mucositis and quality of life of patients undergoing head and neck cancer treatment: randomized clinical trial.
Martins AFL; Pereira CH; Morais MO; de Sousa-Neto SS; Valadares MC; Freitas NMA; Leles CR; de Mendonça EF
Support Care Cancer; 2023 Aug; 31(9):517. PubMed ID: 37566179
[TBL] [Abstract][Full Text] [Related]
10. Prospective assessment of oral mucositis and its impact on quality of life and patient-reported outcomes during radiotherapy for head and neck cancer.
Franco P; Martini S; Di Muzio J; Cavallin C; Arcadipane F; Rampino M; Ostellino O; Pecorari G; Garzino Demo P; Fasolis M; Airoldi M; Ricardi U
Med Oncol; 2017 May; 34(5):81. PubMed ID: 28386836
[TBL] [Abstract][Full Text] [Related]
11. A multinational, randomized phase III trial of iseganan HCl oral solution for reducing the severity of oral mucositis in patients receiving radiotherapy for head-and-neck malignancy.
Trotti A; Garden A; Warde P; Symonds P; Langer C; Redman R; Pajak TF; Fleming TR; Henke M; Bourhis J; Rosenthal DI; Junor E; Cmelak A; Sheehan F; Pulliam J; Devitt-Risse P; Fuchs H; Chambers M; O'Sullivan B; Ang KK
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):674-81. PubMed ID: 14967419
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of low-level laser therapy and aluminum hydroxide in patients with chemotherapy and radiotherapy-induced oral mucositis.
Lima AG; Antequera R; Peres MP; Snitcosky IM; Federico MH; Villar RC
Braz Dent J; 2010; 21(3):186-92. PubMed ID: 21203698
[TBL] [Abstract][Full Text] [Related]
13. Phenylbutyrate mouthwash mitigates oral mucositis during radiotherapy or chemoradiotherapy in patients with head-and-neck cancer.
Yen SH; Wang LW; Lin YH; Jen YM; Chung YL
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1463-70. PubMed ID: 21840136
[TBL] [Abstract][Full Text] [Related]
14. Oral complications at 6 months after radiation therapy for head and neck cancer.
Lalla RV; Treister N; Sollecito T; Schmidt B; Patton LL; Mohammadi K; Hodges JS; Brennan MT;
Oral Dis; 2017 Nov; 23(8):1134-1143. PubMed ID: 28675770
[TBL] [Abstract][Full Text] [Related]
15. The association between cumulative radiation dose and the incidence of severe oral mucositis in head and neck cancers during radiotherapy.
Sunaga T; Nagatani A; Fujii N; Hashimoto T; Watanabe T; Sasaki T
Cancer Rep (Hoboken); 2021 Apr; 4(2):e1317. PubMed ID: 33295153
[TBL] [Abstract][Full Text] [Related]
16. Low-level laser therapy/photobiomodulation in the management of side effects of chemoradiation therapy in head and neck cancer: part 2: proposed applications and treatment protocols.
Zecha JA; Raber-Durlacher JE; Nair RG; Epstein JB; Elad S; Hamblin MR; Barasch A; Migliorati CA; Milstein DM; Genot MT; Lansaat L; van der Brink R; Arnabat-Dominguez J; van der Molen L; Jacobi I; van Diessen J; de Lange J; Smeele LE; Schubert MM; Bensadoun RJ
Support Care Cancer; 2016 Jun; 24(6):2793-805. PubMed ID: 26984249
[TBL] [Abstract][Full Text] [Related]
17. Confounding factors associated with oral mucositis assessment in patients receiving chemoradiotherapy for head and neck cancer.
Chung YL; Pui NNM
Support Care Cancer; 2017 Sep; 25(9):2743-2751. PubMed ID: 28353040
[TBL] [Abstract][Full Text] [Related]
18. Effect of low-level laser therapy on chemoradiotherapy-induced oral mucositis and salivary inflammatory mediators in head and neck cancer patients.
Oton-Leite AF; Silva GB; Morais MO; Silva TA; Leles CR; Valadares MC; Pinezi JC; Batista AC; Mendonça EF
Lasers Surg Med; 2015 Apr; 47(4):296-305. PubMed ID: 25824475
[TBL] [Abstract][Full Text] [Related]
19. Severe Oral Mucositis After Intensity-Modulated Radiation Therapy for Head and Neck Cancer.
Iovoli AJ; Turecki L; Qiu ML; Khan M; Smith K; Yu H; Ma SJ; Farrugia MK; Singh AK
JAMA Netw Open; 2023 Oct; 6(10):e2337265. PubMed ID: 37819659
[TBL] [Abstract][Full Text] [Related]
20. Multicenter phase II study of an oral care program for patients with head and neck cancer receiving chemoradiotherapy.
Yokota T; Tachibana H; Konishi T; Yurikusa T; Hamauchi S; Sakai K; Nishikawa M; Suzuki M; Naganawa Y; Hagihara T; Tsumaki H; Kubo T; Sato M; Taguri M; Morita S; Eguchi T; Kubota K; Zenda S
Support Care Cancer; 2016 Jul; 24(7):3029-36. PubMed ID: 26887378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
